Global Precision Medicine Market to 2024: Opportunities in the Growth in Investments Related to Gene Characterization - ResearchAndMarkets.com

The "Precision Medicine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global precision medicine market to grow with a CAGR of 8.86% over the forecast period from 2018-2024.

The report on the global precision medicine market provides qualitative and quantitative analysis for the period from 2016 to 2024. The study on precision medicine market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on precision medicine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global precision medicine market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global precision medicine market over the period of 2016 to 2024. Further, the growth matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers

• The growing prevalence of cancer and rare diseases
• Growth in ageing population

2. Restraints

• The high cost associated with precision medicine
• Risks related to data sharing

3. Opportunities

• Growth in investments related to gene characterization

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the precision medicine market.

2. Complete coverage of all the segments in the precision medicine market to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in the global precision medicine market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered:

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Precision Medicine Market Highlights

2.2. Precision Medicine Market Projection

2.3. Precision Medicine Market Regional Highlights

3. Global Precision Medicine Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Technology

3.4.2. Growth Matrix Analysis by Application

3.4.3. Growth Matrix Analysis by End User

3.4.4. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Precision Medicine Market

4. Precision Medicine Market Macro Indicator Analysis

5. Global Precision Medicine Market by Technology

5.1. Companion Diagnostics

5.2. Big Data Analytics

5.3. Drug Discovery

5.4. Bioinformatics

5.5. Gene Sequencing

5.6. Others

6. Global Precision Medicine Market by Application

6.1. Respiratory

6.2. Oncology

6.3. Immunology

6.4. CNS

6.5. Others

7. Global Precision Medicine Market by End User

7.1. Laboratories

7.2. Pharmaceuticals

7.3. Biotechnology Diagnostic Companies

7.4. Others

8. Global Precision Medicine Market by Region 2018-2024

9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Precision Medicine Market

9.2. Companies Profiles

9.2.1. Biocrates Life Sciences AG

9.2.2. Intomics

9.2.3. Eagle Genomics Ltd

9.2.4. Laboratory Corporation Of America Holdings

9.2.5. Novartis AG

9.2.6. Quest Diagnostics Incorporated

9.2.7. Nanostring Technologies

9.2.8. Pfizer Inc.

9.2.9. Teva Pharmaceuticals

9.2.10. Medtronic

For more information about this report visit https://www.researchandmarkets.com/r/vkx6vu

View source version on businesswire.com: https://www.businesswire.com/news/home/20191001005519/en/